102 related articles for article (PubMed ID: 33965402)
1. Adalimumab Induces a Wound Healing Profile in Patients with Hidradenitis Suppurativa by Regulating Macrophage Differentiation and Matrix Metalloproteinase Expression.
Cao Y; Harvey BP; Hong F; Ruzek M; Wang J; Murphy ER; Kaymakcalan Z
J Invest Dermatol; 2021 Nov; 141(11):2730-2740.e9. PubMed ID: 33965402
[TBL] [Abstract][Full Text] [Related]
2. The use of adalimumab to overcome delayed wound healing after wide excision for hidradenitis suppurativa.
Chastagner M; Guillem P; Jullien D; Danset M; Villani AP
Eur J Dermatol; 2024 Apr; 34(2):200-201. PubMed ID: 38907552
[No Abstract] [Full Text] [Related]
3. Golimumab and certolizumab pegol for the treatment of hidradenitis suppurativa: a literature review and future perspective.
Heidari A; Ghane Y; Heidari N; Hosseini S; Goodarzi A
Ther Adv Chronic Dis; 2024; 15():20406223241257342. PubMed ID: 38827348
[TBL] [Abstract][Full Text] [Related]
4. Mast cells are upregulated in hidradenitis suppurativa tissue, associated with epithelialized tunnels and normalized by spleen tyrosine kinase antagonism.
Flora A; Jepsen R; Kozera EK; Woods JA; Cains GD; Radzieta M; Jensen SO; Malone M; Frew JW
Exp Dermatol; 2024 Jan; 33(1):e14894. PubMed ID: 37522746
[TBL] [Abstract][Full Text] [Related]
5. Transcription Factor Activity Regulating Macrophage Heterogeneity during Skin Wound Healing.
Zandigohar M; Pang J; Rodrigues A; Roberts RE; Dai Y; Koh TJ
J Immunol; 2024 Jun; ():. PubMed ID: 38940624
[TBL] [Abstract][Full Text] [Related]
6. Review of therapeutic trends in clinical trials for hidradenitis suppurativa: the rise of biologics and demographic under-representation.
Coleman MS; Mulligan KM; O'Connell KA; Ahmad A; Kim L; da Silva A; Newton J; Dellavalle RP
Clin Exp Dermatol; 2024 Jan; 49(2):172-173. PubMed ID: 37775090
[No Abstract] [Full Text] [Related]
7. Urticarial Vasculitis Induced by Adalimumab Biosimilar in an Elderly Female With Hidradenitis Suppurativa: A Case Report.
Alarnaouti M; Alfaer S; Tallab M; Khojah AA; Magadmi T; Kadasa A; Binsaqr MA
Cureus; 2024 Apr; 16(4):e57722. PubMed ID: 38711695
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of an invasive cervical epidermoid carcinoma in a patient receiving TNF-α blocking therapy for hidradenitis suppurativa.
Ram A; Noël JC; Marmol VD; Benhadou F
JAAD Case Rep; 2018 Oct; 4(9):857-859. PubMed ID: 30306109
[No Abstract] [Full Text] [Related]
9. Financial impact on social security of the incorporation of adalimumab for the treatment of hidradenitis suppurativa: An analysis of the 61-million-contributor Brazilian Social Security System (INSS).
d'Almeida LFV; Borghi de Oliveira AC; Carvalho Neiva B; Queiroz Bastos V; Godinho MP; Azulay DR; Gomes CM
J Eur Acad Dermatol Venereol; 2024 Jun; ():. PubMed ID: 38943373
[No Abstract] [Full Text] [Related]
10. Factors related to the onset and recurrence of flares in hidradenitis suppurativa patients treated with adalimumab.
Caposiena Caro RD; Chiricozzi A; Sechi A; Molinelli E; Venturini M; Candi E; DE Simone C; Peris K; Patrizi A; Offidani A; Calzavara-Pinton P; Bianchi L
Ital J Dermatol Venerol; 2022 Apr; 157(2):137-141. PubMed ID: 33982548
[TBL] [Abstract][Full Text] [Related]
11. Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis.
Jin Y; Lee H; Lee MP; Landon JE; Merola JF; Desai RJ; Kim SC
Arthritis Care Res (Hoboken); 2022 Nov; 74(11):1792-1805. PubMed ID: 33973371
[TBL] [Abstract][Full Text] [Related]
12. Hidradenitis Suppurativa Treated With Apremilast: A Case Series.
Garbayo-Salmons P; Expósito Serrano V; Ribera Pibernat M; Romaní J
Actas Dermosifiliogr (Engl Ed); 2021 May; ():. PubMed ID: 33984314
[No Abstract] [Full Text] [Related]
13. Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa.
Schell SL; Schneider AM; Nelson AM
Exp Dermatol; 2021 Oct; 30(10):1453-1470. PubMed ID: 34018644
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C among patients with hidradenitis suppurativa: a population-based study.
Cohen JM; Kridin K; Perez-Chada LM; Merola JF; Cohen AD
Int J Dermatol; 2022 Jan; 61(1):84-88. PubMed ID: 33998670
[TBL] [Abstract][Full Text] [Related]
15. Intralesional photodynamic therapy in hidradenitis suppurativa: Getting closer to the target.
Garcias-Ladaria J; Corral-Magaña O; Del Pozo LJ; Martín-Santiago A
Photodiagnosis Photodyn Ther; 2021 Jun; 34():102339. PubMed ID: 33992813
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: a systematic literature review and network meta-analysis.
Silverberg JI; Thyssen JP; Fahrbach K; Mickle K; Cappelleri JC; Romero W; Cameron MC; Myers DE; Clibborn C; DiBonaventura M
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1797-1810. PubMed ID: 33991374
[TBL] [Abstract][Full Text] [Related]
17. The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience.
Benfante A; Messina R; Piccionello I; Di Liberti R; Principe S; Scichilone N
Pulm Pharmacol Ther; 2021 Aug; 69():102038. PubMed ID: 33965569
[TBL] [Abstract][Full Text] [Related]
18. Impact of Bariatric Surgery on Hidradenitis Suppurativa.
Canard C; Diaz Cives A; Gaubil-Kaladjian I; Bertin E; Viguier M
Acta Derm Venereol; 2021 Jun; 101(6):adv00471. PubMed ID: 34003299
[No Abstract] [Full Text] [Related]
19. Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials.
Silverberg JI; Simpson EL; Wollenberg A; Bissonnette R; Kabashima K; DeLozier AM; Sun L; Cardillo T; Nunes FP; Reich K
JAMA Dermatol; 2021 Jun; 157(6):691-699. PubMed ID: 33978711
[TBL] [Abstract][Full Text] [Related]
20. Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis.
Nozaki Y; Hidaka T; Ri J; Itami T; Tomita D; Okada A; Ashida C; Ikeda F; Yamamoto A; Funahashi K; Kinoshita K; Matsubara T; Funauchi M; Matsumura I
Front Med (Lausanne); 2021; 8():643459. PubMed ID: 33968956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
